Innoviva, Inc.
Innoviva, Inc. Fundamental Analysis
Innoviva, Inc. (INVA) shows strong financial fundamentals with a PE ratio of 6.34, profit margin of 65.38%, and ROE of 30.60%. The company generates $0.4B in annual revenue with strong year-over-year growth of 14.67%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 81.3/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze INVA's fundamental strength across five key dimensions:
Efficiency Score
ExcellentINVA demonstrates superior asset utilization.
Valuation Score
ExcellentINVA trades at attractive valuation levels.
Growth Score
ModerateINVA shows steady but slowing expansion.
Financial Health Score
ExcellentINVA maintains a strong and stable balance sheet.
Profitability Score
ExcellentINVA achieves industry-leading margins.
Key Financial Metrics
Is INVA Expensive or Cheap?
P/E Ratio
INVA trades at 6.34 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, INVA's PEG of 0.06 indicates potential undervaluation.
Price to Book
The market values Innoviva, Inc. at 1.47 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 4.72 times EBITDA. This is generally considered low.
How Well Does INVA Make Money?
Net Profit Margin
For every $100 in sales, Innoviva, Inc. keeps $65.38 as profit after all expenses.
Operating Margin
Core operations generate -4.01 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $30.60 in profit for every $100 of shareholder equity.
ROA
Innoviva, Inc. generates $16.58 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Innoviva, Inc. generates strong operating cash flow of $169.39M, reflecting robust business health.
Free Cash Flow
Innoviva, Inc. generates strong free cash flow of $167.45M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.60 in free cash annually.
FCF Yield
INVA converts 13.16% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
6.34
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.06
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.47
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.57
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.23
vs 25 benchmark
Current Ratio
Current assets to current liabilities
14.64
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.31
vs 25 benchmark
ROA
Return on assets percentage
0.17
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How INVA Stacks Against Its Sector Peers
| Metric | INVA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 6.34 | 28.45 | Better (Cheaper) |
| ROE | 30.60% | 763.00% | Weak |
| Net Margin | 65.38% | -45265.00% (disorted) | Strong |
| Debt/Equity | 0.23 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 14.64 | 2795.60 | Strong Liquidity |
| ROA | 16.58% | -16588.00% (disorted) | Strong |
INVA outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Innoviva, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
83.61%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
81.67%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
-5.45%
Industry Style: Defensive, Growth, Innovation
Declining